Compare · head to head
Bukwang Pharmaceutical vs Dong-A ST
Bukwang Pharmaceutical ranks higher overall — 360 rank 53 vs 39.
Dong-A ST leads on Value (57 vs 39) and Quality (57 vs 47). Bukwang Pharmaceutical leads on Safety (61 vs 19). The two are close on Growth and Sentiment.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | South Korea | South Korea |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Size | Small | Small |
| ISIN | KR7003000007 | KR7170900005 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 53 | 39 |
| Value | 39 | 57 |
| Quality | 47 | 57 |
| Growth | 64 | 60 |
| Safety | 61 | 19 |
| Sentiment | 43 | 44 |
| Quality details | ||
| Profitability | 61 | 57 |
| Cash Truth | 33 | 58 |
Bukwang Pharmaceutical vs Kwangdong PharmaceuticalBukwang Pharmaceutical vs Bora PharmaceuticalsBukwang Pharmaceutical vs JW PharmaceuticalBukwang Pharmaceutical vs Reyon PharmaceuticalAdd a third stock →
Full analyses: Bukwang Pharmaceutical · Dong-A ST
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100